SCHEMBL29168705

SCHEMBL29168705

COc1ccc(Br)cc1Nc1ncnc2cc(O)c([N+](=O)[O-])cc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 8/20 0.63
▸ ABCG2 Q9UNQ0 3/20 0.60
▸ ALDH1A1 P00352 2/20 0.53
▸ MAPT P10636 2/20 0.53
▸ HTT P42858 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ TNF P01375 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ CRHBP P24387 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ CRHR2 Q13324 1/20 0.53
▸ CTDSP1 Q9GZU7 1/20 0.53
▸ NOD2 Q9HC29 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ NOD1 Q9Y239 1/20 0.53
▸ FBP1 P09467 1/20 0.53
▸ RET P07949 4/20 0.53
▸ KDR P35968 4/20 0.53
▸ KIF5B P33176 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30820443 1.00 EGFR (0.63) EGFRABCG2ALDH1A1MAPTHTT
SCHEMBL30820490 0.90 EGFR (0.76) EGFRABCG2ALDH1A1MAPTHTT
SCHEMBL30820491 0.88 EGFR (0.63) EGFRABCG2ALDH1A1MAPTHTT
SCHEMBL30820511 0.84 EGFR (0.64) EGFRABCG2ALDH1A1MAPTHTT
SCHEMBL30820517 0.84 EGFR (0.64) EGFRABCG2FBP1RETKDR
SCHEMBL17940088 0.77 EGFR (1.00) EGFRABCG2MAPTMAPK1FBP1
SCHEMBL20637508 0.77 EGFR (0.58) EGFRABCG2ALDH1A1MAPTHTT
SCHEMBL4728689 0.75 PDE5A (0.55) EGFRALDH1A1HTTMEN1MAPK1
SCHEMBL30820401 0.75 NPC1 (0.70) EGFRABCG2ALDH1A1MAPTMAPK1
SCHEMBL30820457 0.75 EGFR (0.73) EGFRABCG2MAPTMAPK1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693505-A Heteroaryl derivative compounds and uses thereof 沃若诺伊公司 2024-03-12 — — CN disclosed
Send feedback